SCHEMBL7310248

SCHEMBL7310248

Cc1ccc(C2(O)c3ccccc3Sc3ccccc32)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BCHE P06276 4/20 0.39
OPRM1 P35372 3/20 0.36
OPRK1 P41145 2/20 0.36
OPRL1 P41146 2/20 0.36
CYP1A2 P05177 2/20 0.34
CYP3A4 P08684 2/20 0.34
KMT2A Q03164 2/20 0.34
HTT P42858 2/20 0.34
NPSR1 Q6W5P4 2/20 0.34
ALDH1A1 P00352 1/20 0.34
THRB P10828 1/20 0.34
CYP2C9 P11712 1/20 0.34
CYP2C19 P33261 1/20 0.34
PDK2 Q15119 3/20 0.33
MAOA P21397 2/20 0.33
MEN1 O00255 1/20 0.33
POLB P06746 1/20 0.33
ADORA3 P0DMS8 1/20 0.33
GAA P10253 1/20 0.33
MAPT P10636 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21880254 0.85 BCHE (0.35) BCHECYP1A2CYP3A4KMT2AHTT
SCHEMBL7322303 0.84 P2RX1 (0.44) BCHECYP1A2CYP3A4KMT2AHTT
SCHEMBL1758080 0.84 OPRM1 (0.42) OPRM1OPRK1OPRL1PDK2POLB
SCHEMBL13848433 0.81 PDK2 (0.38) BCHEOPRL1CYP3A4KMT2AHTT
SCHEMBL7320476 0.81 LMNA (0.42) BCHEOPRM1OPRK1OPRL1KMT2A
SCHEMBL7320511 0.79 PDK2 (0.47) OPRM1OPRK1OPRL1KMT2ANPSR1
SCHEMBL13940072 0.78 PDK2 (0.40) BCHEOPRM1OPRK1OPRL1CYP1A2
SCHEMBL7315720 0.77 KIF11 (0.46) OPRM1OPRK1OPRL1PDK2ALOX12
SCHEMBL22169961 0.76 POLB (0.31) POLB
SCHEMBL888093 0.75 NPC1 (0.40) BCHECYP1A2CYP3A4NPSR1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6162824-A NERVOUS SYSTEM DISORDERS; PSYCHOLOGICAL DISORDERS ALLELIX NEUROSCIENCE INC. 2000-12-19 US disclosed
WO-1999041227-A1 TRICYCLIC COMPOUNDS AS GLYCINE TRANSPORT INHIBITORS ALLELIX NEUROSCIENCE, INC. (US) 1999-08-19 WO disclosed